Table 3.
Variables associated with delayed times to transplant
| Variable | Group | Indication to consult >90 d, N, % | P value | Consult to transplant >120 d, N, % | P value | CR to transplant >90 d, N, % | P value | Indication to transplant >180 d, N, % | P value |
|---|---|---|---|---|---|---|---|---|---|
| Age, y | ≤56 | 21/160, 13 | 0.87 | 32/160, 20 | 0.3 | 55/160, 34 | 0.59 | 34/160,21 | .3 |
| >56 | 22/153, 14 | 39/153, 25 | 58/153, 38 | 41/153,27 | |||||
| Sex | Male | 18/163, 11 | 0.2 | 42/163, 29 | 0.2 | 64/163, 39 | 0.27 | 37/163,23 | .68 |
| Female | 25/150, 17 | 29/150, 19 | 49/150, 33 | 38/150,25 | |||||
| Ancestry† | European | 21/214, 10 | 0.005∗ | 40/214, 19 | 0.019∗ | 66/214, 31 | 0.006∗ | 42/214,20 | .012∗ |
| Non-European | 22/99, 22 | 31/99, 31 | 47/99, 47 | 33/99, 33 | |||||
| HCT-CI | 0-2 | 22/183, 12 | 0.38 | 38/183, 21 | 0.41 | 63/183, 34 | 0.5 | 38/183, 21 | .15 |
| 3+ | 21/130, 16 | 33/130, 25 | 50/130, 38 | 37/130, 28 | |||||
| Graft source | HLA-identical sibling | 5/67, 7 | 0.11 | 8/67, 12 | <0.001∗ | 17/67, 25 | 0.024∗ | 10/67, 15 | .004∗ |
| 8/8 URD | 20/149, 13 | 36/149, 24 | 62/149, 42 | 36/149, 24 | |||||
| CB | 11/69, 16 | 11/69, 16 | 19/69, 28 | 15/69, 22 | |||||
| Haploidentical | 3/17, 18 | 10/17, 59 | 9/17, 53 | 10/17, 59 | |||||
| mmURD | 4/11, 36 | 6/11, 55 | 6/11, 55 | 4/11, 36 | |||||
| Referral type | Internal | 17/199, 9 | <0.001∗ | 56/199, 28 | 0.004∗ | 59/199, 30 | 0.003∗ | 47/199, 24 | .9 |
| External | 26/114, 23 | 15/114, 13 | 54/114, 47 | 28/114, 25 | |||||
| Period | Prepandemic | 32/260, 12 | 0.16 | 59/260, 19 | >0.9 | 92/260, 35 | 0.7 | 63/260, 24 | .9 |
| Pandemic | 11/53, 21 | 12/53, 23 | 21/53, 40 | 12/53, 23 |
∗
P values denote significant differences.
†
Time from transplant indication to transplant was >180 days in 10 of 28 (36%) White Hispanic, 9 of 23 (36%) African, and 5 of 28 (18%) Asian-ancestry patients.